Company ProfilePremium

Virbac

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Virbac - Healthcare showcase

Year Founded & Workforce

1968

4,825 Employees

Industry

Healthcare

Services

Virbac Biologicals & Diagnostics
V

Virbac Employee Contacts

113 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Virbac Overview

Company Headquarters: Carros, Southeastern France, France

Founded: 1968

Workforce: ~4825

Company Working: Virbac develops, manufactures, and markets a wide range of veterinary pharmaceutical products and has a market experience of more than fifty years and is one of the top 10 players in the global animal health market. It operates through the livestock and aquaculture business segments, and manufactures products including parasiticides, immunology, antibiotics/dermatology, specialties, equine, and specialized pet food. The company has a presence in more than 100 countries and generates more than 60% of its revenue from outside Europe. It has 11 manufacturing units in different countries and five fully equipped R&D facilities for the development of products.

Strategy

Virbac focuses on providing innovative and high-quality products to the end users and emphasizes enhancing customer satisfaction. It also focuses on collaborative activities to expand its geographic presence and strengthening its presence in the market.

Company Snapshot

$909.93M

Revenue

4,825

Employees

1968

Founded

Carros, Southeastern France, France

Headquarters

SWOT Analysis

Strengths

  • Unique and innovative product offerings
  • Wide customer base
  • Strong distribution channel
  • Strong marketing strategies

Weaknesses

  • Increasing cost of operations
  • Dependence on one product for revenue generation

Opportunities

  • Increasing need for healthcare
  • Acquisitions and in-licensing development opportunities

Threats

  • Patent infringements
  • Stringent government regulations and policies
  • Increasing competition

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Virbac
    • Virbac Biologicals & Diagnostics

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: SBU breakup-0 rose from USD 909.9 Mn in 2015 to USD 933.8 Mn in 2017.
Virbac — By Business Segment
Series (USD Mn)201520162017
SBU breakup-0909.9927.5933.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.